Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alwextin 3.0% Cream in Epidermolysis Bullosa
NCT00825565Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Feb 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Alwextin in epidermolysis bullosa (EB), sponsored by Northwestern University. Started Feb 2009; status: completed.
02
Drugs
Alwextin
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on NCT00825565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00825565.